CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

142 hedge funds and large institutions have $907M invested in Cymabay Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
+11
Holders Change %
+8.4%
% of All Funds
3.08%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
26
Increased
48
Reduced
35
Closed
15
Calls
$1.62M
Puts
$852K
Net Calls
+$766K
Net Calls Change
+$970K
Name Holding Trade Value Shares
Change
Shares
Change %
PA
151
Profund Advisors
Maryland
-$142K -18,066 Closed
PRC
152
Pearl River Capital
Michigan
-$74K -9,400 Closed
CG
153
Cutler Group
California
-$18K -2,400 Closed
Group One Trading
154
Group One Trading
Illinois
-$9K -1,156 Closed
IA
155
IFP Advisors
Florida
-$8K -1,020 Closed
PCM
156
Prelude Capital Management
New York
-$7K -905 Closed
GWM
157
Geneos Wealth Management
Colorado
-$3K -400 Closed